Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human Layilin Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Supplier: R&D Systems™ 2536LA025/CF
This item is not returnable.
View return policy
Description
The Recombinant Human Layilin Protein is derived from NS0. The Recombinant Human Layilin Protein has been validated for the following applications: Binding Activity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| Observed Molecular Wt: 30-35kDa, reducing conditions, Predicted Molecular Wt.: 24.1kDa | |
| 25μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |
| 143903 | |
| Layilin | |
| Mouse myeloma cell line,NS0-derived human Layilin protein Ala22-Glu220,with a C-terminal 10-His tag | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction